SCHEMBL5595644

SCHEMBL5595644

Fc1ccc(CNCCCN2CCNCC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.57
CYP2D6 P10635 2/20 0.57
SCN5A Q14524 2/20 0.55
CHRM2 P08172 1/20 0.54
SIGMAR1 Q99720 3/20 0.54
SLC6A2 P23975 1/20 0.49
SLC6A4 P31645 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KCNH2 Q12809 1/20 0.49
CYP2C19 P33261 1/20 0.48
ACHE P22303 3/20 0.45
MCHR1 Q99705 1/20 0.45
ALDH1A1 P00352 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CXCR4 P61073 1/20 0.43
MPO P05164 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27914058 0.91 CYP3A4 (0.68) CYP3A4CYP2D6SCN5ACHRM2SIGMAR1
SCHEMBL2447920 0.89 CHRM2 (0.62) CYP3A4CYP2D6SCN5ACHRM2CYP2C19
SCHEMBL23686873 0.86 SCN5A (0.67) CYP3A4CYP2D6SCN5ACHRM2CYP2C19
SCHEMBL12332531 0.84 CHRM2 (0.66) CYP3A4CYP2D6SCN5ACHRM2SIGMAR1
SCHEMBL5595495 0.83 CYP3A4 (0.55) CYP3A4CYP2D6CHRM2SIGMAR1CYP2C19
SCHEMBL3997594 0.82 CYP2C19 (0.70) CYP3A4CYP2D6SCN5ACHRM2SIGMAR1
SCHEMBL5595516 0.82 CHRM2 (0.57) CYP3A4CYP2D6CHRM2SIGMAR1CYP2C19
SCHEMBL5595311 0.80 KCNJ1 (0.65) CYP3A4CYP2D6CHRM2SIGMAR1KCNH2
SCHEMBL5754907 0.80 SIGMAR1 (0.70) CYP3A4CYP2D6SCN5ASIGMAR1SLC6A2
SCHEMBL7392786 0.79 CHRM2 (0.58) CYP3A4CYP2D6SCN5ACHRM2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809288-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2007-07-25 EP disclosed
WO-2006051489-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2006-05-18 WO disclosed